The impact of increasing polypharmacy on prescribed drug expenditure-A register-based study in Sweden 2005-2009

Health Policy

Volumn 109, Issue 2, 2013, Pages 166-174

  Hovstadius, Bo ^a   Petersson, Göran ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Drug cost; Polypharmacy; Prescribed drugs; Register

Indexed keywords

ARTICLE; DRUG COST; DRUG USE; HUMAN; POLYPHARMACY; PRESCRIPTION; PREVALENCE; SWEDEN;

DRUG COSTS; DRUG PRESCRIPTIONS; HUMANS; POLYPHARMACY; REGISTRIES; SWEDEN;

EID: 84872290816     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2012.09.005     Document Type: Article

References (47)

1. OECD. Health at glance: Europe 2010. OECD Publishing; 2010 [cited; available from: ]. doi:10.1787/health_glance-2010-en.
2. OECD. Health at a glance 2011: OECD indicators. OECD Publishing; 2011 [cited; available from: ]. doi:10.1787/health_glance-2011-en.
3. Dubois R.W., Chawla A.J., Neslusan C.A., Smith M.W., Wade S. Explaining drug-spending trends: does perception match reality?. Health Affairs (Project Hope) 2000, 19(March-April (2)):231-239.
4. Sale of pharmaceutical in Sweden. Läkemedelsförsäljningen i Sverige. Stockhom: The National Board of Health and Welfare. Socialstyrelsen; 2010.
5. Henriksson F., Hjortsberg C., Rehnberg C. Pharmaceutical expenditure in Sweden. Health Policy 1999, 47(May (2)):125-144.
6. Gerdtham U.G., Lundin D. Why did drug spending increase during the 1990s? A decomposition based on Swedish data. Pharmacoeconomics 2004, 22(1):29-42.
7. Thorpe K.E. The rise in health care spending and what to do about it. Health Affairs (Project Hope) 2005, 24(November-December (6)):1436-1445.
8. Fink K.S., Byrns P.J. Changing prescribing patterns and increasing prescription expenditures in medicaid. Annals of Family Medicine 2004, 2(September-October (5)):488-493.
9. Morgan SG Prescription drug expenditures and population demographics. Health Services Research 2006 Apr, 41(2):411-428.
10. Zuvekas S.H., Cohen J.W. Prescription drugs and the changing concentration of health care expenditures. Health Affairs (Project Hope) 2007, 26(January-February (1)):249-257.
11. Drug sales in Sweden - analysis and prognosis. Stockholm: The National Board of Health and Welfare; 2011.
12. Drug sales in Sweden - analysis and prognosis. Stockholm: The National Board of Health and Welfare; 2006.
13. Drug sales in Sweden - analysis and prognosis. Stockholm: The National Board of Health and Welfare; 2009.
14. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. American Journal of Geriatric Pharmacotherapy 2007, 5(December (4)):345-351.
15. Gorard D.A. Escalating polypharmacy. QJM: Monthly Journal of the Association of Physicians 2006, 99(November (11)):797-800.
16. Hovstadius B., Hovstadius K., Astrand B., Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clinical Pharmacology 2010, 10:16.
17. Hovstadius B., Astrand B., Persson U., Petersson G. Acquisition cost of dispensed drugs in individuals with multiple medications - a register-based study in Sweden. Health Policy 2011, 101(July (2)):153-161.
18. Haider S.I., Johnell K., Thorslund M., Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. International Journal of Clinical Pharmacology and Therapeutics 2007, 45(December (12)):643-653.
19. Bjerrum L., Rosholm J.U., Hallas J., Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology 1997, 53(1):7-11.
20. Colley C.A., Lucas L.M. Polypharmacy: the cure becomes the disease. Journal of General Internal Medicine 1993, 8(May (5)):278-283.
21. Wettermark B., Hammar N., MichaelFored C., Leimanis A., Otterblad Olausson P., Bergman U., et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiology and Drug Safety 2007, 167(July):726-735.
22. Bjerrum L., Sogaard J., Hallas J., Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. European Journal of Clinical Pharmacology 1998, 54(May (3)):197-202.
23. Viktil K.K., Blix H.S., Moger T.A., Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. British Journal of Clinical Pharmacology 2007, 63(February 2):187-195.
24. Haider S.I., Johnell K., Weitoft G.R., Thorslund M., Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. Journal of the American Geriatrics Society 2009, 57(January (1)):62-69.
25. Flaherty J.H., Perry H.M., Lynchard G.S., Morley J.E. Polypharmacy and hospitalization among older home care patients. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2000, October (55)(10):M554-M559.
26. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Journal of the American Medical Association 2002, 287(January (3)):337-344.
27. Pharmaceutical - statistics for 2010: Official Statistics of Sweden.
28. Tandvård och läkemedelsförmånsverket (The Dental and Pharmaceutical Benefits Agency); 2009 [cited 2009-07-31]. Available from: http://www.tlv.se/lakemedel/hogkostnadsskyddet/sa-fungerar-det/.
29. Astrand B., Hovstadius B., Antonov K., Petersson G. The Swedish national pharmacy register. Studies in Health Technology and Informatics 2007, 129:345-349.
30. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivela S.L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology 2002, 55(August (8)):809-817.
31. Hagstrom B., Mattsson B., Wimo A., Gunnarsson R.K. More illness and less disease? A 20-year perspective on chronic disease and medication. Scandinavian Journal of Public Health 2006, 34(6):584-588.
32. Jyrkka J., Vartiainen L., Hartikainen S., Sulkava R., Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. European Journal of Clinical Pharmacology 2006, 62(February (2)):151-158.
33. Ananth J., Parameswaran S., Gunatilake S. Side effects of atypical antipsychotic drugs. Current Pharmaceutical Design 2004, 10(18):2219-2229.
34. McGavock H. Prescription-related illness-a scandalous pandemic. Journal of Evaluation in Clinical Practice 2004, 10(November (4)):491-497.
35. Chutka D.S., Takahashi P.Y., Hoel R.W. Inappropriate medication use in the elderly. Essential Psychopharmacology 2005, 6(6):331-340.
36. Ananth J., Parameswaran S., Gunatilake S. Antipsychotic polypharmacy. Current Pharmaceutical Design 2004, 10(18):2231-2238.
37. Kaiser Family Fondation. Prescription Drug Trends; 2010 [cited 2011-06-13]. Available from: http://www.kff.org/rxdrugs/upload/3057-08.pdf.
38. Krigsman K., Melander A., Carlsten A., Ekedahl A., Nilsson J.L. Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs. Pharmacy World and Science 2007, 29(February (1)):19-24.
39. Banthin J.S., Miller G.E. Trends in prescription drug expenditures by medicaid enrollees. Medical Care 2006, 44(May (5 Suppl.)):I27-I35.
40. Thorpe K.E., Howard D.H. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. Health Affairs (Project Hope) 2006, 25(September-October (5)):w378-w388.
41. Hovstadius B., Petersson G. Factors leading to excessive polypharmacy. Clinics in Geriatric Medicine 2012, 28(May (2)):159-172.
42. Hovstadius B., Tågerud S., Petersson G., åstrand B. Prevalence and therapeutic intensity of dispensed drug groups for individuals with multiple medications: a register-based study of 2.2 million individuals. Journal of Pharmaceutical Health Services Research. 2010, 1:145-155.
43. Salazar J.A., Poon I., Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opinion on Drug Safety 2007, 6(November (6)):695-704.
44. Tinetti M.E., Bogardus S.T., Agostini J.V. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. New England Journal of Medicine 2004, 351(December (27)):2870-2874.
45. Moen J., Norrgård S., Antonov K., Nilsson J.L.G., Ring L. GPs' perceptions of multiple-medicine use in older patients. Journal of Evaluation in Clinical Practice 2010, 16(1):69-75.
46. Cahir C., Fahey T., Teeling M., Teljeur C., Feely J., Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. British Journal of Clinical Pharmacology 2010, 69(May (5)):543-552.
47. Steinman M.A., Landefeld C.S., Rosenthal G.E., Berthenthal D., Sen S., Kaboli P.J. Polypharmacy and prescribing quality in older people. Journal of the American Geriatrics Society 2006, 54(October (10)):1516-1523.